Your browser doesn't support javascript.
loading
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma.
Carvajal, Richard D; Wong, Michael K; Thompson, John A; Gordon, Michael S; Lewis, Karl D; Pavlick, Anna C; Wolchok, Jedd D; Rojas, Patrick B; Schwartz, Jonathan D; Bedikian, Agop Y.
Affiliation
  • Carvajal RD; Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: carvajar@mskcc.org.
  • Wong MK; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Thompson JA; Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Gordon MS; Pinnacle Oncology Hematology, Scottsdale, AZ, USA.
  • Lewis KD; University of Colorado Denver, Aurora, CO, USA.
  • Pavlick AC; New York University, New York, NY, USA.
  • Wolchok JD; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Rojas PB; ImClone Systems LLC, a wholly-owned subsidiary of Eli Lilly and Company, Bridgewater, NJ, USA.
  • Schwartz JD; ImClone Systems LLC, a wholly-owned subsidiary of Eli Lilly and Company, Bridgewater, NJ, USA.
  • Bedikian AY; MD Anderson Cancer Center, Houston, TX, USA.
Eur J Cancer ; 50(12): 2099-107, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24930625
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Dacarbazine / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Dacarbazine / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2014 Document type: Article